[Breast cancer resistance protein and diabetes]

Area of Science:

• Pharmacology
• Metabolic Diseases
• Biochemistry

Background:

• Diabetes mellitus is a complex metabolic disorder.
• Drug transporters, like ATP-binding cassette (ABC) transporters, play crucial roles in drug disposition.
• Breast Cancer Resistance Protein (BCRP) is an ABC transporter vital for protecting normal tissues.

Purpose of the Study:

• To review the intricate relationship between diabetes and BCRP.
• To elucidate how diabetes impacts BCRP expression and function.
• To understand the implications of altered BCRP in diabetes treatment.

Main Methods:

• Literature review of studies investigating diabetes and BCRP.
• Analysis of research on BCRP expression and activity in diabetic models.
• Synthesis of findings on drug absorption and efflux affected by BCRP in diabetes.

Main Results:

• Diabetic conditions have been shown to impair BCRP function and expression, particularly in the intestine.
• This impairment affects the absorption and efflux of various drugs.
• Altered BCRP activity is linked to the challenges in treating diabetes mellitus.

Conclusions:

• The interplay between diabetes and BCRP is significant.
• Understanding BCRP's role in diabetes is crucial for optimizing drug therapy.
• Further research into BCRP modulation may offer new avenues for diabetes management.